ATE298571T1 - Flüssige pharmazeutische formulierungen mit verbesserter oraler veträglichkeit - Google Patents

Flüssige pharmazeutische formulierungen mit verbesserter oraler veträglichkeit

Info

Publication number
ATE298571T1
ATE298571T1 AT01987156T AT01987156T ATE298571T1 AT E298571 T1 ATE298571 T1 AT E298571T1 AT 01987156 T AT01987156 T AT 01987156T AT 01987156 T AT01987156 T AT 01987156T AT E298571 T1 ATE298571 T1 AT E298571T1
Authority
AT
Austria
Prior art keywords
pharmaceutical formulations
liquid pharmaceutical
improved oral
oral tolerability
tolerability
Prior art date
Application number
AT01987156T
Other languages
English (en)
Inventor
Kuo-Chung Mark Lee
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of ATE298571T1 publication Critical patent/ATE298571T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01987156T 2000-12-04 2001-11-30 Flüssige pharmazeutische formulierungen mit verbesserter oraler veträglichkeit ATE298571T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/729,406 US6391886B1 (en) 2000-12-04 2000-12-04 Oral compositions having improved consumer aesthetics
PCT/US2001/045035 WO2002045714A1 (en) 2000-12-04 2001-11-30 Drug formulation having improved oral tolerability

Publications (1)

Publication Number Publication Date
ATE298571T1 true ATE298571T1 (de) 2005-07-15

Family

ID=24930887

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01987156T ATE298571T1 (de) 2000-12-04 2001-11-30 Flüssige pharmazeutische formulierungen mit verbesserter oraler veträglichkeit

Country Status (11)

Country Link
US (1) US6391886B1 (de)
EP (1) EP1339408B1 (de)
JP (1) JP2004515478A (de)
CN (1) CN100577166C (de)
AR (1) AR031450A1 (de)
AT (1) ATE298571T1 (de)
AU (1) AU2002239397A1 (de)
DE (1) DE60111769T2 (de)
MX (1) MXPA03004941A (de)
PE (1) PE20020694A1 (de)
WO (1) WO2002045714A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030211136A1 (en) * 1998-09-25 2003-11-13 Neema Kulkarni Fast dissolving orally consumable films containing a sweetener
MXPA03008056A (es) * 2001-03-05 2004-10-15 Johnson & Johnson Composiciones farmaceuticas liquidas con sabor oculto.
US20030060422A1 (en) 2001-08-31 2003-03-27 Balaji Venkataraman Tannate compositions and methods of treatment
DE10208313A1 (de) * 2002-02-27 2003-09-11 Boehringer Ingelheim Pharma Ambroxol für die Behandlung von schmerzhaften Zuständen im Mund und Rachenraum
US20040028622A1 (en) * 2002-08-12 2004-02-12 Michael Gurin Multifunctional flavor systems and method of use
EP1565153A4 (de) * 2002-11-22 2008-10-01 Noville Inc Orale zusammensetzungen, die den salzigengeschmack von salzen maskieren
US20040142084A1 (en) * 2003-01-21 2004-07-22 Knueven Carl J. Alkali metal bisulfates to mask aftertaste of artificial sweeteners
US20040185093A1 (en) * 2003-03-18 2004-09-23 Szymczak Christopher E. Compositions containing sucralose
EP1466949A1 (de) * 2003-04-10 2004-10-13 Symrise GmbH & Co. KG Nichttoxische Beschichtungszusammensetzung, Verwendungsverfahren und gegen die Anlagerung von Biofouling-Organismen behandelte Gegenstände
US7632531B2 (en) * 2003-04-11 2009-12-15 International Flavors & Fragnances Inc. Alkyldienamides exhibiting taste and sensory effect in flavor compositions
US7361376B2 (en) * 2003-04-11 2008-04-22 International Flavors & Fragrances Inc. Alkyldienamides exhibiting taste and sensory effect in flavor compositions
US6884906B2 (en) * 2003-07-01 2005-04-26 International Flavors & Fragrances Inc. Menthyl half acid ester derivatives, processes for preparing same, and uses thereof for their cooling/refreshing effect in consumable materials
US7141686B2 (en) 2003-07-10 2006-11-28 International Flavors & Fragrances Inc. E2, E4, Z8-undecatrienoic acid and ester and carboxamide derivatives thereof, organoleptic uses thereof and processes for preparing same
US7329767B2 (en) * 2003-10-03 2008-02-12 International Flavors & Fragrances Inc. Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof
US8007839B2 (en) * 2003-10-03 2011-08-30 International Flavors & Fragrances Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof
US7482378B2 (en) * 2004-05-28 2009-01-27 Millenium Specialty Chemicals, Inc. Physiological cooling compositions
US20060034784A1 (en) * 2004-08-12 2006-02-16 The Procter & Gamble Company Oral compositions and systems
EP1669056A3 (de) * 2004-08-12 2007-05-30 The Procter and Gamble Company Mundpflegemittel und System
US7427421B2 (en) * 2004-09-10 2008-09-23 International Flavors & Fragrances Inc. Saturated and unsaturated N-alkamides exhibiting taste and flavor enhancement effect in flavor compositions
US7541055B2 (en) * 2004-09-10 2009-06-02 International Flavors & Fragrances Inc. Saturated and unsaturated N-alkamides exhibiting taste and flavor enhancement effect in flavor compositions
US20060062811A1 (en) * 2004-09-21 2006-03-23 Szymczak Christopher E Medicinal cooling emulsions
RU2407522C2 (ru) * 2005-10-24 2010-12-27 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Болеутоляющие композиции n,2,3-триметил-2-изопропилбутамида местного действия и способы их применения
WO2007089652A2 (en) * 2006-01-27 2007-08-09 Cadbury Adams Usa Llc Flavor-enhancing compositions, methods of manufacture, and methods of use
US7803353B2 (en) * 2006-03-29 2010-09-28 The Procter & Gamble Company Oral care compositions having improved consumer aesthetics and taste
EP1958627A3 (de) * 2007-01-04 2010-09-01 Symrise GmbH & Co. KG Verwendung bestimmter Menthyl-3-oxocarbonsäureester als physiologisch wirksame Kühlsubstanzen
JP2009007311A (ja) * 2007-06-29 2009-01-15 Lintec Corp ジフェンヒドラミン−アセスルファム付加物、その製造方法及び該付加物を含有する経口製剤
KR20120118495A (ko) * 2010-04-21 2012-10-26 테이코쿠 팔마 유에스에이, 인코포레이티드 국부 마취제 에멀전 조성물 및 이의 제조 및 사용 방법
KR101297354B1 (ko) * 2011-01-13 2013-08-19 동광제약주식회사 안정하고 불쾌한 맛이 차폐된 덱시부프로펜을 함유한 투명한 시럽 조성물
CA2831566A1 (en) * 2011-03-31 2012-10-04 Jitendra Krishan Somani Menthol liquids composition
EP3086793B1 (de) 2013-12-24 2022-05-11 Virginia Commonwealth University Verwendung von oxygenierten cholesterinsulfaten (ocs) zur behandlung von nierenstörungen
ES2972665T3 (es) * 2015-03-26 2024-06-13 Patheon Softgels Inc Cápsulas liquisoft
JP6794758B2 (ja) * 2015-10-21 2020-12-02 大正製薬株式会社 経口液体医薬組成物
GB2551971B (en) * 2016-06-29 2020-09-16 Syri Ltd Taste masked liquid pharmaceutical composition of mebeverine or pharmaceutically acceptable salts thereof
CA3032750C (en) * 2016-09-01 2021-04-13 The Procter & Gamble Company Medication with improved taste and sensory experience
EP3863676A1 (de) * 2018-10-09 2021-08-18 Symrise AG Zusammensetzungen mit guaifenesin und aromaverbindungen, die eine isovanilylgruppe enthalten
US12053447B2 (en) 2019-06-25 2024-08-06 NuBioPharma, LLC Oral solution and powder to liquid compositions of balsalazide
CN112439077A (zh) * 2019-08-29 2021-03-05 鲁南制药集团股份有限公司 一种矫味剂组合物、制备方法及其用途
CN112439072A (zh) * 2019-08-29 2021-03-05 鲁南制药集团股份有限公司 一种掩味组合物及其制备方法、用途
EP4132476A1 (de) 2020-04-10 2023-02-15 The Procter & Gamble Company Rheologische feste orale zusammensetzung
CN111714477B (zh) * 2020-07-23 2021-06-15 山东迅达康兽药有限公司 祛痰组合物及其口服液制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136163A (en) 1971-02-04 1979-01-23 Wilkinson Sword Limited P-menthane carboxamides having a physiological cooling effect
CA1027347A (en) 1972-07-20 1978-03-07 David G. Rowsell Compounds having a physiological cooling effect and compositions containing them
JPS5888334A (ja) 1981-11-20 1983-05-26 Takasago Corp ３−ｌ−メントキシプロパン−１、２−ジオ−ル
US4853212A (en) 1987-07-13 1989-08-01 Warner-Lambert Company Reduced base content chewing gum compositions having anesthetic properties
US4822597A (en) 1987-07-13 1989-04-18 Warner-Lambert Company Anesthetic-containing chewing gum compositions
US5009893A (en) * 1989-07-17 1991-04-23 Warner-Lambert Company Breath-freshening edible compositions of methol and a carboxamide
US5196436A (en) * 1990-10-31 1993-03-23 The Procter & Gamble Company Dextromethorphan antitussive compositions
DE69314025T2 (de) 1992-05-18 1998-04-16 Procter & Gamble Zusammensetzungen mit kühleffekt
EP0725630A1 (de) * 1993-10-28 1996-08-14 The Procter & Gamble Company Schnellösliche arzneidosisformen enthaltend magnesium-aluminium-silikat und mehrfachwirkstoffe
US5616621A (en) 1995-01-30 1997-04-01 American Home Products Corporation Taste masking liquids
US5843466A (en) 1995-08-29 1998-12-01 V. Mane Fils S.A. Coolant compositions
US5725865A (en) 1995-08-29 1998-03-10 V. Mane Fils S.A. Coolant compositions
US5766622A (en) * 1996-08-14 1998-06-16 The Procter & Gamble Company Inhibiting undesirable taste in oral compositions
WO1998052545A1 (en) 1997-05-22 1998-11-26 The Boots Company Plc Pharmaceutical compositions of flurbiprofen and burn-masking agent for treating sore throat
JP4300652B2 (ja) * 1998-09-21 2009-07-22 大正製薬株式会社 経口用固形製剤
US6596298B2 (en) * 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
JP2000273050A (ja) 1999-03-19 2000-10-03 Kobayashi Pharmaceut Co Ltd 苦みがマスキングされた液状製剤
US7067116B1 (en) * 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1

Also Published As

Publication number Publication date
DE60111769D1 (de) 2005-08-04
AR031450A1 (es) 2003-09-24
WO2002045714A1 (en) 2002-06-13
JP2004515478A (ja) 2004-05-27
MXPA03004941A (es) 2003-09-10
CN1575175A (zh) 2005-02-02
US6391886B1 (en) 2002-05-21
PE20020694A1 (es) 2002-09-25
EP1339408B1 (de) 2005-06-29
CN100577166C (zh) 2010-01-06
EP1339408A1 (de) 2003-09-03
AU2002239397A1 (en) 2002-06-18
DE60111769T2 (de) 2006-04-20

Similar Documents

Publication Publication Date Title
ATE298571T1 (de) Flüssige pharmazeutische formulierungen mit verbesserter oraler veträglichkeit
ATE355271T1 (de) Pharmazeutische zusammensetzung
DE60118008D1 (de) Pharmazeutische zusammensetzungen mit amlodipinmaleat
ITTO20010008A0 (it) Formulazione farmaceutica
ATE331529T1 (de) Antigen enthaltende pharmazeutische zusammensetzung
ATE307571T1 (de) Pharmazeutische formulierung enthaltend bicalutamid
ATE317260T1 (de) Pharmazeutische formulierungen mit platinderivaten
NO20030627D0 (no) Hydrogel-drevet medikament doseringsform
DE69936002D1 (de) Angepasster löffel zur oralen medikamenten-verabreichung
DK1194153T3 (da) Smagsmaskerede flydende farmaceutiske formuleringer
ATE311915T1 (de) Medikamentenspender
DE60135273D1 (de) Geschmacksmaskierte pharmazeutische Partikel
ATE334656T1 (de) Flüssige pharmazeutische zusammensetzung
NO20020464D0 (no) Flerkomponent-farmasöytisk doseringsform
NO20030713L (no) Oral faststoffdose vaksine
DE602004016967D1 (de) Flüssige pharmazeutische palonosetronformulierungen
DE59915033D1 (de) Pharmazeutische Zubereitung
ATA59499A (de) Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung
NO20015670D0 (no) Forbedrede farmasöytiske formuleringer
DE60129238D1 (de) Pharmazeutische zusammensetzung
ATE350016T1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
AR025867A1 (es) Formulacion portasdora farmaceutica
DE10291905D2 (de) Pharmazeutische Zusammensetzung
ATE350029T1 (de) Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
DE10107261B4 (de) Pharmazeutische Zusammensetzung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties